Julie Selkirk is currently the Executive Director, Biology at Radionetics Oncology, bringing new cell therapies to patients with Bit. Bio's opti-ox cell coding technology. With a background in neuroscience and pharmacology, Julie has held various leadership roles in companies such as Bristol Myers Squibb, Celgene, Vertex Pharmaceuticals, Pfizer, and Neurocrine Biosciences. With a Ph.D. in Cell Biology and Receptor Pharmacology from the University of Leicester, Julie has a strong educational background to support her successful career in the pharmaceutical industry.
March, 2022 - present
Applied Science Manager at Amazon
Senior Global Director Sustainability, Science & Innovation at Microsoft
Principal Applied Data Science Manager at Microsoft
Director, Global Threat Research at Pfizer
Head Of Croci Company Analysis Team And Co-head Of DWS Micro Research at DWS Group
Access the worlds's biggest network of public org charts
Learn more